SUBSCRIBE TO TMCnet
TMCnet - World's Largest Communications and Technology Community

TMC NEWS

TMCNET eNEWSLETTER SIGNUP

Research and Markets: GSK's Fendrix (Prophylactic Hepatitis B Virus Vaccines) Market 2014- Forecast Opportunities to 2022
[April 17, 2014]

Research and Markets: GSK's Fendrix (Prophylactic Hepatitis B Virus Vaccines) Market 2014- Forecast Opportunities to 2022


DUBLIN --(Business Wire)--

Research and Markets (http://www.researchandmarkets.com/research/ch937q/fendrix) has announced the addition of the "Fendrix (Prophylactic Hepatitis B Virus Vaccines) - Forecast and Market Analysis to 2022" report to their offering.

Fendrix [Hepatitis B (rDNA) Vaccine (adjuvanted, adsorbed)] is GSK's monovalent vaccine that protects patients against acute and chronic infections caused by all identified strains of HBV. Since 2005, Fendrix has been approved in the 5EU for the active immunization of patients =15 years of age with renal insufficiency (i.e., pre-hemodialsis and hemodialysis).

Scope

- Overview of Hepatitis B disease, including epidemiology, etiology, symptoms, diagnosis, pathology and treatment guidelines as well as an overview on the competitive landscape.


- Detailed information on Fendrix including product description, safety and efficacy profiles as well as a SWOT analysis.

- Sales forecast for Fendrix for top eight countries from 2012 to 2022.

- Sales information covered for the US, France, Germany, Italy, Spain, UK, Japan and Canada.

Key Topics Covered:

1 Tables & Figures

2 Introduction

3 Disease Overview

3.1 Overview

3.2 Etiology and Pathophysiology

3.2.1 Etiology

3.2.2 Pathophysiology

3.3 Symptoms

3.4 Prognosis (News - Alert)

4 Vaccination Recommendations and Coverage Rates

4.1 Overview

5 Competitive Assessment

5.1 Overview

5.2 Strategic Competitor Assessment

6 Fendrix

6.1 Overview

6.2 Immunogenicity

6.3 Safety

6.4 SWOT Analysis

6.5 Forecast

7 Appendix

For more information visit http://www.researchandmarkets.com/research/ch937q/fendrix


[ Back To TMCnet.com's Homepage ]






Technology Marketing Corporation

35 Nutmeg Drive Suite 340, Trumbull, Connecticut 06611 USA
Ph: 800-243-6002, 203-852-6800
Fx: 203-866-3326

General comments: tmc@tmcnet.com.
Comments about this site: webmaster@tmcnet.com.

STAY CURRENT YOUR WAY

© 2017 Technology Marketing Corporation. All rights reserved | Privacy Policy